المؤلفون: Adeel AA; College of Medicine, King Saud University, Riyadh, Saudi Arabia. aaadeel@yahoo.com., Elnour FA; National Malaria Control Programme, Federal Ministry of Health, Khartoum, Sudan., Elmardi KA; National Malaria Control Programme, Federal Ministry of Health, Khartoum, Sudan., Abd-Elmajid MB; National Malaria Control Programme, Federal Ministry of Health, Khartoum, Sudan., Elhelo MM; National Malaria Control Programme, Federal Ministry of Health, Khartoum, Sudan., Ali MS; National Malaria Control Programme, Federal Ministry of Health, Khartoum, Sudan., Adam MA; National Malaria Control Programme, Federal Ministry of Health, Khartoum, Sudan., Atta H; Malaria Control and Elimination, Division of Communicable Diseases Control, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt., Zamani G; Malaria Control and Elimination, Division of Communicable Diseases Control, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt., Warsame M; Global Malaria Programme, World Health Organization, Geneva, Switzerland., Barrette A; Global Malaria Programme, World Health Organization, Geneva, Switzerland., Mohammady HE; Naval Medical Research Unit-3, Cairo, Egypt., Nada RA; Naval Medical Research Unit-3, Cairo, Egypt.

المصدر: Malaria journal [Malar J] 2016 May 21; Vol. 15 (1), pp. 285. Date of Electronic Publication: 2016 May 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875 (Electronic) Linking ISSN: 14752875 NLM ISO Abbreviation: Malar J Subsets: MEDLINE

مواضيع طبية MeSH: Drug Resistance*, Antimalarials/*therapeutic use , Artemisinins/*therapeutic use , Ethanolamines/*therapeutic use , Fluorenes/*therapeutic use , Malaria, Falciparum/*drug therapy , Plasmodium falciparum/*drug effects , Pyrimethamine/*therapeutic use , Sulfadoxine/*therapeutic use, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antimalarials/pharmacology ; Artemether, Lumefantrine Drug Combination ; Artemisinins/pharmacology ; Artesunate ; Child ; Child, Preschool ; Dihydropteroate Synthase/genetics ; Drug Combinations ; Ethanolamines/pharmacology ; Female ; Fluorenes/pharmacology ; Genetic Markers ; Genotype ; Humans ; Infant ; Infant, Newborn ; Malaria, Falciparum/parasitology ; Male ; Middle Aged ; Plasmodium falciparum/genetics ; Plasmodium falciparum/isolation & purification ; Pyrimethamine/pharmacology ; Sudan ; Sulfadoxine/pharmacology ; Tetrahydrofolate Dehydrogenase/genetics ; Treatment Outcome ; Young Adult

المؤلفون: Adeel AA; College of Medicine, King Saud University, Riyadh, Saudi Arabia. aaadeel@yahoo.com., Saeed NA; The National Malaria Control Programme, Ministry of Public Health and Population, Sanaa, Yemen. niazabdo@yahoo.com., Aljasari A; The National Malaria Control Programme, Ministry of Public Health and Population, Sanaa, Yemen. aljasari@hotmail.com., Almohager AM; Ministry of Public Health and Population, Sanaa, Yemen. almohaget76@gmail.com., Galab MH; Ministry of Public Health and Population, Sanaa, Yemen. Dr.ghalab.husami@gmail.com., AlMahdi A; Ministry of Public Health and Population, Sanaa, Yemen. Amaryahya2016@gmail.com., Mahammed MH; Ministry of Public Health and Population, Sanaa, Yemen. mansour777788436@gmail.com., AlDarsi M; Ministry of Public Health and Population, Sanaa, Yemen. Mohammedaldarasi@yahoo.com., Salaeah YA; Ministry of Public Health and Population, Sanaa, Yemen. yaamer2010@gmail.com., Atta H; Malaria Control and Elimination, Division of Communicable Diseases Control, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt. attah@who.int., Zamani G; Malaria Control and Elimination, Division of Communicable Diseases Control, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt. zamanig@who.int., Warsame M; Global Malaria Programme, World Health Organization, Geneva, Switzerland. warsamem@who.int., Barrette A; Global Malaria Programme, World Health Organization, Geneva, Switzerland. barrettea@who.int., Mohammady HE; Naval Medical Research Unit-3, Cairo, Egypt. Hanan.ElMohammady.eg@med.navy.mil., Nada RA; Naval Medical Research Unit-3, Cairo, Egypt. Rania.AbdelKhalek.eg@med.navy.mil.

المصدر: Malaria journal [Malar J] 2015 Nov 14; Vol. 14, pp. 449. Date of Electronic Publication: 2015 Nov 14.

نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875 (Electronic) Linking ISSN: 14752875 NLM ISO Abbreviation: Malar J Subsets: MEDLINE

مواضيع طبية MeSH: Artemisinins/*administration & dosage , Ethanolamines/*administration & dosage , Fluorenes/*administration & dosage , Malaria, Falciparum/*drug therapy , Pyrimethamine/*administration & dosage , Sulfadoxine/*administration & dosage, Adolescent ; Adult ; Aged ; Artemether, Lumefantrine Drug Combination ; Child ; Child, Preschool ; Drug Combinations ; Humans ; Infant ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome ; Yemen ; Young Adult

المؤلفون: Warsame M; Division of International Health, Karolinska Institutet, Stockholm, Sweden. warsamem@who.int, Atta H, Klena JD, Waqar BA, Elmi HH, Jibril AM, Hassan HM, Hassan AM

المصدر: Acta tropica [Acta Trop] 2009 Feb; Vol. 109 (2), pp. 146-51. Date of Electronic Publication: 2008 Nov 05.

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0370374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-6254 (Electronic) Linking ISSN: 0001706X NLM ISO Abbreviation: Acta Trop Subsets: MEDLINE

مواضيع طبية MeSH: Amodiaquine/*therapeutic use , Antimalarials/*therapeutic use , Artemisinins/*therapeutic use , Chloroquine/*therapeutic use , Malaria/*drug therapy , Pyrimethamine/*therapeutic use , Sulfadoxine/*therapeutic use, Artesunate ; Child ; Child, Preschool ; Drug Combinations ; Drug Therapy, Combination ; Female ; Humans ; Infant ; Male ; Somalia ; Treatment Outcome